peptides for recovery bpc 157 BPC-157 Peptide Therapy Benefits Peptide Power: A Practical Guide

J Xenobiot

Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing

the exact volume depends on the concentration a given research protocol calls for

This is educational info for research purposes, not medical advice